Nuvo Announces 2009 second quarter financi...((131) (43) (315) ---------...),Health

Date:8/7/2009

(131) (43) (315) ------------------------------------------------------------------------- 2,921 3,948 7,702 7,371 ------------------------------------------------------------------------- Net Loss and total comprehensive loss (1,664) (2,864) (4,532) (5,135) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Net loss per common share - basic and diluted (0.01) (0.01) (0.01) (0.02) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Average number of common shares outstanding - basic and diluted (millions) 352.6 303.1 336.2 301.3 ------------------------------------------------------------------------- ------------------------------------------------------------------------- NUVO RESEARCH INC. CONSOLIDATED STATEMENTS OF CASH FLOWS Three-months Six-months ended ended June 30, June 30, June 30, June 30, Unaudited 2009 2008 2009 2008 (thousands of Canadian dollars) $ $ $ $ ------------------------------------------------------------------------- OPERATING ACTIVITIES Net loss (1,664) (2,864) (4,532) (5,135) Items not involving current cash flows: Amortization 148 207 297 412 Deferred revenue recognized (560) (450) (1,120) (711)
'/>"/>

SOURCE Nuvo Research Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2. NATB Announces Partnership With Ronald McDonald House Charities(R)
3. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
6. AMN Healthcare Announces Second Quarter 2009 Results
7. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
8. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
9. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
10. Feline Pine Announces National Take Your Cat to the Vet Day August 22
11. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock